Evidence map›Paper›PMID 40464072›Full record

ArticleAngewandte Chemie (International ed. in English)2025

A Platform for the Development of Highly Red-Shifted Azobenzene-Based Optical Tools.

Kyra Lützel, Henryk Laqua, Manjima B Sathian, Benedikt Nißl, Judit Katalin Szántó, Christina-Anna Senser, Gökcen Savasci, Lars Allmendinger, Bilal Kicin, Vincent Ruf and 8 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. The Structures Obtained from the Oxidation of 3-Amino-1The Journal of organic chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Impact of C-Terminal PKC Phosphorylation on TRPC6 Current Kinetics.International journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. A Platform for the Development of Highly Red-Shifted Azobenzene-Based Optical Tools.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Kyra Lützel *Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.ORCID https://orcid.org/0009-0003-8083-4848
Henryk Laqua *Department of Chemistry, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
Manjima B Sathian *Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
Benedikt Nißl *Department of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
Judit Katalin SzántóDepartment of Chemistry, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.ORCID https://orcid.org/0000-0003-4767-0987
Christina-Anna SenserInstitute of Pharmacy, University of Regensburg, Universitätsstr. 31, Regensburg, 93040, Germany.
Gökcen SavasciDepartment of Chemistry, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
Lars AllmendingerDepartment of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
Bilal KicinDepartment of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
Vincent RufDepartment of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
Dominik KammererChair for Photonics and Optoelectronics, Nano-Institute Munich, Department of Physics, Ludwig-Maximilians-Universität München, Königinstraße 10, Munich, 80539, Germany.
Theobald LohmüllerChair for Photonics and Optoelectronics, Nano-Institute Munich, Department of Physics, Ludwig-Maximilians-Universität München, Königinstraße 10, Munich, 80539, Germany.
Konstantin KaraghiosoffDepartment of Chemistry, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
Ahmed M AliDepartment of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
Ursula StorchWalther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität München, Goethestr. 33, Munich, 80336, Germany.
Michael Mederos Y SchnitzlerWalther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität München, Goethestr. 33, Munich, 80336, Germany.
Christian OchsenfeldDepartment of Chemistry, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.
David B KonradDepartment of Pharmacy, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, Munich, 81377, Germany.ORCID https://orcid.org/0000-0001-5718-8081

Funding

Assembly Controlled Chemical Photocatalysis 444632635Deutsche Forschungsgemeinschaft 239283807Walter Benjamin Program 529879166
6 · The paper itself

Abstract

Azobenzenes are versatile photoswitches that can be used to generate elaborate optical tools, including photopharmaceuticals. However, the targeted application-guided design of new photoswitches with specific properties remains challenging. We have developed synthetic protocols for derivatives of the dfdc (di-ortho-fluoro-di-ortho-chloro) azobenzene scaffold with chemical alterations in the para-/ortho-positions and performed an in-depth study into the effects of their structures on their photophysical properties with an emphasis on the n → π* absorption band using NMR, UV-vis, and X-ray analysis. The data was used to establish and validate a computational approach that allows to compute realistic UV-vis spectra by combining TD-DFT excited-state calculations from 6000 thermally accessible structures generated through MD simulations while considering the high structural flexibility of ortho-substituted azobenzenes. We added 15 new visible light-operated photoswitches to the toolbox for the development of optical devices with relaxation rates across multiple orders of magnitude and identified several examples with stronger bathochromic shifts than the dfdc azobenzene lead structure. Our combined experimental and computational study forms the foundation for the advanced in silico design and synthesis of new highly red-shifted photoswitches. To showcase the potential of dfdc azobenzenes for the development of chemical tools, we synthesized dfdc-OptoBI-1 and demonstrated its biological activity as a red light-operated activator of TRPC6 channels in HEK293 cells.

Indexed as

Chemical probe developmentIn silico designPhotophysical propertiesRed‐shifted azobenzenes

Identifiers

PMID40464072
PMCPMC12322654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.